A 2026 BRFSS analysis involving 4,071 U.S. adults who used cannabis and either smoked cigarettes, vaped nicotine, or did both found a strong modality match: people who vaped tobacco were much more likely to vape cannabis than to smoke cannabis.1 For addiction and harm-reduction assessment, the pattern is a route-specific risk signal because smoking, vaping, …
A 2026 emergency department claims analysis estimated 3.87 million United States ED visits in 2021 where take-home naloxone could have been clinically relevant, compared with 226,453 ED-treated opioid-overdose visits in the same database.1 The finding reframes naloxone distribution as an emergency-care workflow for overdose risk, polysubstance exposure, long-term opioid use, and patients who arrive after …
A 2026 survey of 38 drug checking services found that Latin American programs faced a different operating reality than US programs: funding was a major barrier more often (80% vs. 54%), drug checking equipment was legally permitted less often (44% vs. 75%), and law enforcement confiscation of checking supplies was reported more often (38% vs. …
A 2026 Australian interview study involving 27 adults with methamphetamine use problems found that 21 participants, or 77.8%, had never previously sought treatment for methamphetamine use. Research Highlights Most had never sought treatment: Peart et al. interviewed 27 adults and found that 77.8% had not previously sought methamphetamine treatment before entering the parent trial.1 3 …